3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Conditions
Urogenital Neoplasms
1
Prostatic Neoplasms
1
Lung Neoplasms
1
Interventions
taletrectinib
1
dabrafenib
1
capmatinib
1
brigatinib
1
belagenpumatucel L
1
Suspensions
1
Powders
1
Paclitaxel
1
BID protein, human
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
Lung Neoplasms
×
Suspensions
×
Clear all
NCT03756311
2026-01-23
Expanded Access to NanoPac
NanOlogy, LLC
No longer available